Investor Login

Category: Uncategorized

Vaneltix planning to enroll subjects in new round of clinical trials

On Tuesday, February 21st 2023, Bound Brook, NJ – Vaneltix Pharma, Inc. (Formerly Urigen Pharmaceuticals, Inc.; “Vaneltix” or “the Company”),…
Read More
Vaneltix Pharma, Inc.
317 George St., Ste. 400,
New Brunswick, NJ 08901
United States

  • Tel:

    (732) 354-3217

  • Fax:

    (732) 354-3205

  • Email:

    Info@vaneltix.com
2021 © Vaneltix. All rights reserved.
Privacy Policy
Privacy Policy
This website is created by Blink.